STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY UNKNOWN_NEUROVASCULAR_PRODUCT; CATHETER, PERCUTANEOUS
|
Back to Search Results |
|
Catalog Number UNK_NEU |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Stroke/CVA (1770); Headache (1880); Hematoma (1884); Intracranial Hemorrhage (1891); Perforation (2001); Vasoconstriction (2126); Obstruction/Occlusion (2422); Pseudoaneurysm (2605); Thromboembolism (2654); Vascular Dissection (3160)
|
Event Date 02/07/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
H3 other text : the device is not available to the manufacturer.
|
|
Event Description
|
Post-market clinical follow-up (pmcf) anonymous survey was conducted for the subject balloon guide catheter.The survey was conducted in france, germany, italy, spain and united states.During the survey, symptomatic intracranial hemorrhage, stroke, vessel cutoff downstream, vessel dissection perforation, thromboembolic event, access site complications (pseudoaneurysm or hematoma), spasm requiring medication and headaches were reported to have occurred as per the responses received.No other information is available about the events reported in the survey.
|
|
Manufacturer Narrative
|
Although the dhr (device history record) could not be reviewed because the lot number remains unknown, there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.It was reported during a post-market clinical follow-up (pmcf) survey conducted for stryker merci® balloon guide catheter (bgc) device #¿s (5) 90073 and (12) 90074 in france, germany, italy, spain and united states that in one case a number of patient complications were noted: ¿patient intracranial hemorrhage', 'patient stroke', 'patient vessel occlusion',' patient vessel dissection', 'patient thromboembolic event', 'patient vasospasm serious', 'patient headache serious', 'patient hematoma', 'patient pseudoaneurysm', and 'patient vessel perforation'.The patients' outcome was unknown.The risk of the above reported list of patient harms is documented in the merci device directions for use (dfu), as a potential adverse event which can occur as a result of these type of procedures.There was no indication of device malfunction or failure, therefore an assignable cause of anticipated procedural complication, will be assigned to the reported events.
|
|
Event Description
|
Post-market clinical follow-up (pmcf) anonymous survey was conducted for the subject balloon guide catheter.The survey was conducted in france, germany, italy, spain and united states.During the survey, symptomatic intracranial hemorrhage, stroke, vessel occlusion, vessel dissection perforation, thromboembolic event, access site complications (pseudoaneurysm or hematoma), spasm requiring medication and headaches were reported to have occurred as per the responses received and medical intervention was required.No other information is available about the events reported in the survey.
|
|
Search Alerts/Recalls
|
|
|